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AbsTrACT
Introduction For every woman who dies during pregnancy 
and childbirth, many more suffer ill-health, the burden of 
which is highest in low-resource settings. We sought to 
assess the extent and types of maternal morbidity.
Methods Descriptive observational cross-sectional study 
at primary-level and secondary-level healthcare facilities 
in India, Pakistan, Kenya and Malawi to assess physical, 
psychological and social morbidity during and after pregnancy. 
Sociodemographic factors, education, socioeconomic 
status (SES), quality of life, satisfaction with health, reported 
symptoms, clinical examination and laboratory investigations 
were assessed. Relationships between morbidity and 
maternal characteristics were investigated using multivariable 
logistic regression analysis.
results 11 454 women were assessed in India (2099), 
Malawi (2923), Kenya (3145), and Pakistan (3287). Almost 
3 out of 4 women had ≥1 symptoms (73.5%), abnormalities 
on clinical examination (71.3%) or laboratory investigation 
(73.5%). In total, 36% of women had infectious morbidity of 
which 9.0% had an identified infectious disease (HIV, malaria, 
syphilis, chest infection or tuberculosis) and an additional 
32.5% had signs of early infection. HIV-positive status was 
highest in Malawi (14.5%) as was malaria (10.4%). Overall, 
47.9% of women were anaemic, 11.5% had other medical or 
obstetric conditions, 25.1% reported psychological morbidity 
and 36.6% reported social morbidity (domestic violence and/
or substance misuse). Infectious morbidity was highest in 
Malawi (56.5%) and Kenya (40.4%), psychological and social 
morbidity was highest in Pakistan (47.3%, 60.2%). Maternal 
morbidity was not limited to a core at-risk group; only 1.2% 
had all four morbidities. The likelihood of medical or obstetric, 
psychological or social morbidity decreased with increased 
education; adjusted OR (95% CI) for each additional level of 
education ranged from 0.79 (0.75 to 0.83) for psychological 
morbidity to 0.91 (0.87 to 0.95) for infectious morbidity. 
Each additional level of SES was associated with increased 
psychological morbidity (OR 1.15 (95% CI 1.10 to 1.21)) and 
social morbidity (OR 1.05 (95% CI 1.01 to 1.10)), but there 
was no difference regarding medical or obstetric morbidity. 
However, for each morbidity association was heterogeneous 
between countries.
Conclusion Women suffer significant ill-health which is 
still largely unrecognised. Current antenatal and postnatal 
care packages require adaptation if they are to meet the 
identified health needs of women.
InTroduCTIon
All women have the right to the highest 
attainable standard of health and well-being.1 
Health is a state of complete (physical, 
psychological and social) well-being and not 
merely the absence of disease or infirmity.2 
Commonly, the number of women who die 
Key questions
What is already known?
 ► Non-life-threatening maternal morbidity is a new 
concept internationally.
 ► This is the first study to comprehensively measure 
the burden of non-acute maternal morbidity during 
and after pregnancy using a standardised approach 
to assess the physical, psychological and social 
components of ill-health in combination with 
objective clinical and laboratory measurements.
What are the new findings?
 ► Almost three out of four women had ≥one 
symptoms (73.5%), abnormalities on clinical 
examination (71.3%) or laboratory investigation 
(73.5%).
 ► In total, 9.0% of women had an identified infectious 
disease (HIV, malaria, syphilis, chest infection or 
tuberculosis); 32.5% had signs of early infection, 
with a presumptive source of infection identifiable 
in more than two-thirds of women using simple 
clinical algorithms and point-of-care tests.
 ► Overall, 47.9% of women were anaemic, 11.5% 
were diagnosed with other medical or obstetric 
morbidity, 25.1% of women reported psychological 
morbidity and 36.6% reported social morbidity 
(domestic violence and/or substance misuse).
 ► Maternal morbidity was not limited to a core 
‘at-risk’ group; only 1.2% of women had a 
combination of all four morbidities.
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during and after pregnancy (maternal mortality) is used 
as an international health indicator and the new Sustain-
able Development Goal (3.1) aims to reduce the global 
maternal mortality ratio to <70 per 1 00 000 live births 
by 2030.3 However, the number of women who die only 
represent the ‘tip of the iceberg’.4 The shape of this 
‘iceberg’ and the true magnitude of, and relative propor-
tion for, each category including maternal morbidity, 
is currently poorly documented. For every woman who 
dies, an estimated 20 or 30 more suffer morbidity related 
to pregnancy and childbirth.5 6 However, these estimates 
are not based on standard, well-documented method-
ology and have limited usefulness for informing strategy. 
There is also an assumption that there is a relationship 
and continuum, such that maternal morbidity may 
increase the risk of more severe acute maternal morbidity 
(SAMM) and subsequently maternal death. Similarly, 
prevention or treatment of ill-health is expected to result 
in fewer women with life-threatening morbidity or death. 
While the underlying causes of maternal mortality and 
type of maternal morbidity may not be simply connected, 
it is recognised that many women suffer both long-term 
and short-term consequences of pregnancy and child-
birth, the major burden of which rests on women living 
in low-income and middle-income countries (LMIC).7
Until now, research has focused on severe and 
life-threatening acute maternal morbidity, also termed 
maternal ‘near miss’, which has now been well defined 
and generally is assessed at secondary or tertiary care 
levels.8 It is estimated that up to 15% of women will 
have a complication during pregnancy, childbirth, or 
in the postnatal period, which will require emergency 
obstetric care.9 Similarly, the recent Global Burden of 
Disease Study estimates related to pregnancy are based 
on modelling for acute complications during pregnancy 
and childbirth only.10 In contrast, morbidity which is not 
immediately life-threatening and/or morbidity perceived 
as ill-health by the woman herself, is poorly documented.
A recent suggested definition for non-severe maternal 
morbidity is ‘any health condition attributed to and/or compli-
cating pregnancy, and childbirth that has a negative impact on 
the woman’s well-being’.11 Currently, there is a lack of under-
standing of what type and extent of ill-health women 
suffer during and after pregnancy and to date the burden 
of non-severe maternal morbidity has not been measured 
in an approach that is comprehensive, standardised or 
comparable across different settings.
There are a number of previous studies that have 
used a variety of clinical or proxy indicators (eg, 
hospital admission, complications of labour, serious 
adverse incidents) or documented specific single or 
multiple known disease conditions only (eg, pre-ec-
lampsia, haemorrhage) over different time frames.8 12 
However, in the available literature, sample sizes are 
limited and the indicators used are not consistent. The 
Global Burden of Disease Study reported that non-fatal 
dimensions of disease and injury are more important 
than ever before and highlighted that currently limited 
information is available for maternal ill-health.10 Simi-
larly, health and well-being are centrally positioned 
in the 2030 Agenda for sustainable development and 
there is a call for more accurate measures of and data 
on health, including for maternal morbidity.3
In this study, we therefore sought to measure maternal 
morbidity in a comprehensive and standardised manner 
by asking women about symptoms, conducting clinical 
examination for signs and point-of-care investigations 
to assess obstetric, medical and infectious morbidity. In 
addition, psychological as well as social ill-health was 
assessed using both objective and subjective measures.
Our primary objective was to assess the prevalence and 
type of maternal morbidity during and after pregnancy in 
women living in low-income and middle-income settings. 
As a secondary objective, we explore the relationship 
between educational level and socioeconomic status 
(SES) of women and medical or obstetric, infectious, 
psychological and social morbidity.
MeTHods
study design and settings
We conducted a descriptive observational cross-sectional 
study in India, Pakistan, Kenya and Malawi. In three of 
these four countries, geographical areas were purposively 
selected to include both urban and rural women seeking 
care at primary as well as secondary level healthcare 
facilities (Pakistan, Islamabad Capital Territory (ICT) 
and Punjab; Kenya, Central; Malawi, South). In India, 
the study population was from the largest public health 
hospital in New Delhi, which provides routine antenatal 
(ANC) and postnatal care (PNC) to a large and diverse 
catchment population. In Pakistan, two hospitals in 
ICT and all three district hospitals for three districts in 
Punjab, together with five health centres selected using 
simple random sampling were included. For Kenya and 
Malawi, in each district, to reflect a cross-section of two 
levels of healthcare (primary and secondary) the main 
hospital was purposively selected and in addition two 
health centres that referred to this hospital were selected 
Key questions
What do the new findings imply?
 ► This study for the first time highlights a significant burden of 
ill-health during and after pregnancy that has largely been ‘hidden’ 
and/or underestimated.
 ► At present, when women attend for antenatal and postnatal care in 
low-income and middle-income settings, their heath needs are not 
assessed; and point-of-care tests and screening for psychological 
and social morbidity are not routinely available at primary and 
secondary level.
 ► It is important to use the data from this study to improve the 
content and quality of antenatal and postnatal care packages 
so that women’s health needs during and after pregnancy are 
assessed and that individualised care which meets the identified 
health needs of each woman is provided.
 o
n
 4 M
ay 2018 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2017-000625 on 3 May 2018. Downloaded from 
McCauley M, et al. BMJ Glob Health 2018;3:e000625. doi:10.1136/bmjgh-2017-000625 3
BMJ Global Health
using simple random sampling. This provided a sample 
of 12 secondary and 17 primary care level facilities 
(see online supplementary table 1).
With regard to healthcare coverage and uptake, the 
proportion of women who attend for at least one ANC 
visit is 75% in India, 73% in Pakistan, 92% in Kenya and 
96% in Malawi.13 For skilled attendance at birth (or insti-
tutional delivery), this is up to 81% in India, 61.8% in 
Pakistan, 89.8% in Kenya and 90% in Malawi.14
Participants
All women attending for ANC, delivery or PNC at the 
study healthcare facilities were eligible for inclusion. 
Women with possible SAMM and/or who were too ill 
to participate (eg, altered conscious level as a result 
of eclampsia, receiving treatment for an acute compli-
cation, admission to high dependency unit) were 
excluded. Similar numbers of women were recruited at 
five stages of pregnancy—early antenatal (≤20 weeks), 
late antenatal (>21 weeks), delivery (within 24 hours 
of birth), early postnatal (days 1–7) and late postnatal 
(weeks 1–12) (see online supplementary table 2). 
Women were recruited sequentially between December 
2014 and September 2015 until the target sample size 
for each assessment point was reached in each health-
care facility. All women who consented to take part in 
the study were interviewed and had a full clinical exam-
ination and basic urine and serological investigations 
performed by trained healthcare providers. Data were 
collected using a newly developed and standardised 
structured questionnaire formatted onto iPads in India, 
Pakistan and Kenya. Paper questionnaires were used in 
Malawi.
Each woman was only enrolled once in the study and 
was assessed by a trained healthcare provider (including 
nurse-midwives and/or other staff cadres who were 
responsible for providing ANC and PNC in that setting). 
Training in how to conduct the full assessment (including 
full history taking, clinical and obstetric examination, 
point-of-care testing and investigations) was provided 
by the same team of research leads in each setting 
and included practical assessment of competency and 
observed assessments. In each setting, the data collection 
tool was piloted and checked with regard to consistent use 
and understanding of the language used. Data collection 
was supervised by the most senior healthcare provider 
in each setting. The training included sessions to ensure 
healthcare providers knew when referral was needed 
and could provide this. Finally, particular emphasis was 
placed on professional conduct and the need for confi-
dentiality, privacy and respectful care. Supervisors (senior 
healthcare providers) were appointed at secondary level 
and checked (via direct observation) 10% of all assess-
ments conducted, and, were also available to provide 
advice regarding women who required referral. Weekly 
supervisory and coordination meetings (virtual) were 
arranged with the supervisory team based in the UK for 
each setting.
data collection
Demographics including age, marital status, occupation 
and educational level (measured as level completed: 
none, primary, secondary or tertiary) were assessed. 
SES was derived using Kuppuswamy’s scale in India and 
Pakistan (using women as head of household).15 SES 
was defined using wealth index derived using principal 
component analysis for Malawi and Kenya.16 17
Current physical symptoms were assessed using 76 
questions covering six organ systems—cardiopulmo-
nary, gastrointestinal, musculoskeletal, urogynaecology, 
obstetric and breast, and miscellaneous (dermatology, 
endocrine, neurological, immunology, ear-nose-throat).
Psychological morbidity was assessed using the Edin-
burgh Postnatal Depression Scale (EPDS) with depression 
defined as an EPDS score of ≥10.18 Questions regarding 
quality of life (QOL) and satisfaction with health were 
derived from the WHO ‘QOL Spirituality, Religious-
ness and Personal Beliefs (SRPB)’ questionnaire.19 The 
‘Hurt, Insulted, Threatened, Screamed at’ (HITS) ques-
tionnaire was used to assess domestic violence first from 
the husband or partner and second from other family 
members (with a score of >10 indicating significant 
abuse).20 Four subquestions from the ‘Alcohol, Smoking 
and Substance Involvement Screening Test’ question-
naire were included.21
Clinical observations pulse rate (PR), respiratory rate 
(RR), blood pressure (BP) and oral temperature (T) were 
measured and the conjunctiva, sclera, breast, abdomen 
(general and obstetric) were examined. Inspection of 
the perineum and/or speculum examination was only 
conducted if clinically indicated (eg, for symptoms of 
vaginal discharge or bleeding).
Assessment of morbidity
Occurrence of each symptom and sign was individually 
evaluated. Where possible, documentation of symptoms, 
signs and investigations were ‘triangulated’ and grouped 
as indicative of specific maternal morbidities, for example, 
headache, visual disturbances, upper abdominal pain, 
raised BP plus proteinuria indicative of pre-eclampsia. 
A reported symptom of a productive cough of >2 weeks 
was used to indicate either a possible chest infection or 
suspected tuberculosis (TB). Antenatal haemorrhage 
was defined as women who reported bleeding per vagina 
during pregnancy and/or who had this confirmed on 
examination. Incontinence was defined as women who 
reported any leakage of urine and/or had this confirmed 
on examination.
Urinalysis was performed using Multistix GP. A simple 
finger prick test was used to obtain one capillary (<0.5 mL) 
of blood for use in four rapid diagnostic point-of-care 
tests: haemoglobin (HemoCue), malaria (Humasis), 
syphilis and HIV (SD BIOLINE HIV/Syphilis Duo) and 
C reactive protein (CRP) (QuickRead). CRP could be 
measured in all settings except in some healthcare facili-
ties at primary level in Malawi and Pakistan. Anaemia was 
classified as haemoglobin <110 g/L.22 Hypertension was 
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classified as BP≥140/90.23 Pre-eclampsia was defined as 
BP≥140/90, and proteinuria (PR >++on urinalysis) after 
20 weeks gestation.23
We amended the systematic inflammatory response 
syndrome (SIRS) score23 to define possible early infec-
tion as the presence of two or more of the following: (1) 
T>38°C or <36°C, (2) PR>90 beats per min; (3) RR>20 
breaths per min or (4) raised CRP (defined as >5 mg/
dL at each assessment point, apart from after delivery 
(within 24 hours of birth) where raised CRP was defined 
as >10 mg/dL).
Summative physical morbidity was categorised as 
(1) infectious or (2) medical or obstetric. Infectious 
morbidity included: HIV, malaria, syphilis, chest infec-
tion or suspected TB, and a SIRS score of ≥2. Medical 
or obstetric morbidity included: anaemia, hypertension, 
pre-eclampsia, antenatal haemorrhage and incontinence. 
We defined psychological morbidity as an EPDS score 
of ≥10 and/or thoughts of self-harm.18 We defined social 
morbidity as a woman reporting any domestic violence 
(HITS score >4) and/or any substance misuse.
sample size calculation and statistical analysis
In Pakistan, Kenya and Malawi for each of the five assess-
ment points, data were collected for a minimum of 576 
women across two levels of healthcare facility (primary 
and secondary) selected by stratified cluster sampling. 
In India, as the study was conducted in one facility 
(secondary level) a cluster sampling approach was not 
required, giving an amended sample size of 1920 with 
a minimum of 384 women per assessment point. This 
sample size had 95% power to detect the presence of 
any morbidity with a prevalence >1%. With a sample size 
exceeding 2000, the margins of error for estimation of 
prevalence of 1%, 10% and 50% do not exceed 0.5%, 
1.4% and 2.2%, respectively. Data analysis was performed 
using SPSS V.22 and Stata V.12.1. Descriptive statistics are 
provided for relevant characteristics by country; these 
provide estimates of the prevalence of these characteris-
tics. For each morbidity, multivariable logistic regression 
analyses were performed using SES and education cate-
gory as covariates. This assumes a common OR for the 
impact of a change to the next category for a covariate. 
Data for all four countries were combined in one set of 
analyses as well as data being analysed separately for each 
country. Analyses of data for all four countries included 
interactions between country and each of SES and educa-
tion to examine evidence of heterogeneity among coun-
tries. Likelihood ratio tests were used to compare logistic 
regression models and derive corresponding p values. A 
p value of <0.05 was used to determine statistical signifi-
cance and estimates provided with robust 95% CIs. OR 
were estimated using multivariable logistic regression 
models for each morbidity. Since there is considerable 
association between SES and education category, the 
multivariable models are reported to enable the contri-
bution of each, after accounting for the other, to be 
distinguished. Unless otherwise stated, all percentages 
reported use the total sample size for the relevant country. 
Where a substantial proportion of women (>10%) had 
data missing for a variable this is reported in the tables. 
Absence of a response for a question used in derivation of 
morbidity was treated as absence of the sign/symptom/
abuse or the most positive response for depression.
ethics
Written informed consent was obtained from each 
woman who participated in the study.
resulTs
study population
A total of 11 454 women across four LMICs were assessed: 
India (2099), Malawi (2923), Kenya (3145) and Pakistan 
(3287) with similar numbers of women assessed at each 
of the five stages of pregnancy (see online supplemen-
tary table 2). The refusal rate was low (between 1.1% and 
2.5%) in each country and was mainly because of lack of 
time for the woman to participate. Following recruitment 
and after taking a clinical history, 150 women (1.3%) 
declined clinical examination and 138 women (1.2%) 
declined laboratory investigations.
Quality of life and satisfaction with health
For all countries combined, the majority of women 
reported having a good QOL (75.9%) and being satis-
fied with their health (78.2%). This was least well scored 
in Pakistan (56.4% satisfied with QOL and 57.4% with 
health) and highest in Malawi (95% satisfied with QOL 
and 95.5% with health).
symptoms
A detailed clinical history was obtained. Almost three-
quarter of all women (8425; 73.5%) reported at least 
one clinical symptom with a median (IQR) of 4.2 (0–27) 
symptoms per woman (figure 1). Women in Pakistan 
and India most frequently reported symptoms (92.1% 
and 90.4% of women, respectively). Overall, when cate-
gorised by organ system, symptoms were most frequently 
related to the gastrointestinal tract (23.9% of all symp-
toms reported) followed by obstetric and breast (16.7%), 
urogynaecological (16.1%) cardiopulmonary (15.5%), 
musculoskeletal (12.8%) and miscellaneous (including 
immunology, dermatology and endocrine) (15.0%). 
There were slight variations in the trend but the most 
common was gastrointestinal symptoms in all four coun-
tries followed by cardiopulmonary symptoms in Malawi 
and Kenya, urogynaecological in Pakistan and obstetric 
or breast related in India.
Psychological and social morbidity
Psychological and social morbidity were assessed as part 
of the clinical history. Psychological morbidity was noted 
in one in four women (25.1%), with 22.2% having an 
EPDS ≥10% and 15.2% of women reporting thoughts 
of self-harm (table 1). Psychological morbidity was 
highest in Pakistan (29.8%) and lowest in Kenya (4.5%). 
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Overall, 3887 women (33.9%) reported domestic violence; 
more frequently from the husband (26.3%) than from 
another family member (15.8%) (table 1). Overall, 8.9% 
of women suffered significant domestic violence (HITS 
score >10) with larger proportions of women in Pakistan 
reporting both any, and, significant domestic violence. Use 
of alcohol, sedatives or inhalants was not common with 
6.5% of women reporting using any of these substances 
within the past 3 months and 1.7% of women requiring 
intervention for substance misuse (table 1).
Infectious, medical and obstetric morbidity
In total, 73.1% of women had at least one or more 
abnormal finding on clinical examination (figure 1). 
Figure 1 Histogram of quality of life, satisfaction with health, number of symptoms, number of abnormal clinical examinations 
and number of abnormal laboratory investigations (percentage of women assessed by country and for all countries combined).
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The most common findings were: conjunctival pallor 
(23.0%), breast problems (16.0%), gum and oral cavity 
problems (12.1%) and abdominal tenderness (10.9%) 
(table 2).
Vaginal examination was only offered, and consent 
obtained, if clinically indicated; perineum examination 
was indicated and performed in 54.9% (6288) of women 
and speculum examination in 22.3% (2555) of women; 
25.9% of women had perineal problems (vaginal tears, 
excoriation, swelling) and 3.3% were noted to have 
leakage of urine (table 2). This is equivalent to an overall 
estimated prevalence of 15.5% for perineal morbidity 
across the four countries, but noted to be particularly high 
among women in Pakistan. Similarly, 36.4% of women 
examined by speculum were noted to have abnormal 
vaginal discharge, and vaginal bleeding was confirmed in 
14.8% giving an overall estimated prevalence of between 
2.4% and 5.1% in India, Kenya and Malawi, but up to 
30.8% among women in Pakistan (table 2).
Reported symptoms, results of clinical examination 
and laboratory investigation were combined where 
appropriate to determine (1) infectious morbidity and 
(2) medical or obstetric morbidity (table 3).
Using an amended SIRS score, 32.5% of women in 
whom CRP was measured had early signs of possible 
infection. In almost two-thirds of cases, a presumptive 
cause or source of infection could be identified (based 
on symptoms and clinical examination), which included: 
gastroenteritis (18.8%), lower respiratory tract infection 
(13.0%), sexually transmitted infection (10.1%), urinary 
tract infection (9.6%), mastitis (7.4%), upper respiratory 
tract infection (4.4%), endometritis (2.0%), chorioamni-
onitis (1.6%) and wound infection (0.6%).
Comorbidity
Overall, one or more type of infectious morbidity 
was identified in 28.0% of women, and, one or more 
type of medical or obstetric morbidity in 50.0% 
(see online supplementary figure 1). Only 22.9% of all 
women had no identifiable morbidity and only 1.2% had 
all four types of morbidity.
Association between maternal morbidity, education and 
socioeconomic status
Separate multivariable analyses for each form of morbidity, 
which assume a consistent effect of SES and education 
across country and account for country and SES, found 
that as education level increases, the likelihood of each 
morbidity (psychological, social, medical or obstetric) 
except infectious conditions decreases (table 4). For 
each additional level of education (primary, secondary or 
higher) completed, the adjusted odds of morbidity were 
estimated to reduce by a factor between 0.79 (95% CI 
0.75 to 0.83) for psychological morbidity and 0.91 (95% 
CI 0.87 to 0.95) for infectious morbidity. Conversely, 
in these analyses, as SES increases (for a fixed educa-
tion category), the likelihood of morbidity increases 
for psychological (OR 1.15 (95% CI 1.10 to 1.21)) and 
Table 1  Psychological and social ill-health of women by country and for all countries combined (total number of women 
assessed n=11 454)
Category India Pakistan Kenya Malawi Total
Number of women 2099 3287 3145 2923 11 454
Psychological morbidity (%)
  EPDS≥10 19.3 41.6 12.3 15.6 22.9
  Thoughts of self-harm 15.6 29.8 4.5 10.1 15.2
  EPDS≥10 and/or thoughts of self-harm 19.8 47.3 13.5 16.4 25.1
Social morbidity (%)
  Domestic violence
   Any domestic violence
 HITS score>4
Husband and/or family 39.7 56.0 21.7 18.2 33.9
Husband 38.6 37.4 18.3 13.6 26.3
Family 10.1 31.8 6.0 12.5 15.8
   Significant
   domestic violence
HITS score>10
Husband and/or family 6.1 21.7 3.2 4.7 8.9
Husband 5.1 12.5 2.4 3.0 6.0
Family 2.7 7.5 0.5 2.6 3.4
  Substance misuse
   Use of alcohol, sedatives, inhalants, tobacco in last 
3 months
2.7 0.2 2.0 1.7 6.5
   Intervention required (ASSIST score>4) 0.8 1.5 1.4 2.8 1.7
   Domestic violence and/or substance misuse 40.3 60.2 25.0 19.8 36.6
ASSIST, Alcohol, Smoking and Substance Involvement Screening Test; EPDS, Edinburgh Postnatal Depression Scale; HITS, Hurt, Insulted, 
Threatened, Screamed at. 
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Table 2  Abnormal findings on clinical examination by country and for all countries combined
Country India Pakistan Kenya Malawi Total
Number of women assessed* 2099 3287 3145 2923 11 454
Clinical examination—general
Variable Definition % % % % %
  Pulse rate
  (PR, beats per min)
PR≤50 or PR≥100 0.7 1.8 7.3 7.4 4.5
  Respiratory rate (RR, breaths per 
min)
RR≤8 or RR≥20 0.1 39.0 72.7 43.2 42.3
  Temperature (T, °C) T≤35 or T≥38.0 15.2 10.6 1.2 3.4 7.0
  Systolic blood pressure (mm Hg) ≤90 or ≥140 2.5 7.3 7.6 4.4 5.8
  Diastolic blood pressure (mm Hg) ≤45 or ≥90 3.0 11.6 4.3 4.4 6.2
  Nutritional status (kg/m2) Body mass index≤18.5 kg/
m2
3.0 2.5 1.5 3.0 2.5
Clinical examination—by organ system
  Organ system Abnormal finding % % % % %
  General Conjunctival pallor 40.9 43.9 6.1 4.7 23.0
Sclera 0.7 3.5 0.1 0.0 1.2
Goitre 0.2 6.3 0.2 0.2 2.0
Peripheral pitting oedema 2.8 13.9 2.6 0.9 5.4
Central pitting oedema 0.3 5.7 0.3 0.5 1.9
Total 45.0 73.3 9.3 6.3 33.5
  Skin Skin rashes 3.5 9.2 1.4 0.7 3.7
Skin ulcers 0.2 2.4 0.2 0.0 0.8
Skin lump or growth 0.4 5.7 0.8 0.2 2.0
Total 4.1 17.3 2.4 0.9 6.5
  Oral cavity Bleeding gums 0.8 14.5 5.3 0.1 6.0
Oral thrush 0.3 9.3 0.5 0.3 3.0
Mouth ulcers 1.6 9.3 0.3 0.1 3.1
Total 2.7 33.1 6.1 0.5 12.1
  Breast Cracked nipples 0.3 12.3 1.3 0.8 4.2
Abnormal engorgement 3.3 20.6 0.7 0.5 6.8
Abnormal tenderness 1.3 11.1 1.0 0.8 3.9
Abscess 0.3 0.9 0.2 0.3 0.4
Lump 1.2 0.8 0.6 0.3 0.7
Total 6.4 45.7 3.8 2.7 16.0
  Abdominal Abnormal tenderness 25.7 17.9 2.4 1.3 10.9
Abnormal mass 0.1 6.3 0.2 0.0 1.9
Total 25.8 24.2 2.6 1.3 12.8
Clinical examination—perineum and speculum examination†
  Number of women with indication and assessed 563 2654 2225 846 6288
  Perineum % % % % %
   Leakage of urine 0.0 7.1 0.6 0.5 3.3
   Excoriation 0.0 12.0 0.5 2.2 5.5
   Swelling 1.2 18.2 1.1 3.2 8.7
   Tear 0.7 18.0 5.9 7.0 10.7
   Subtotal 1.9 55.3 8.1 12.9 28.2
  Percentage of study sample 0.5 44.6 5.7 3.7 15.5
  Number of women with indication and assessed 365 1729 316 154 2555
Continued
 o
n
 4 M
ay 2018 by guest. Protected by copyright.
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2017-000625 on 3 May 2018. Downloaded from 
8 McCauley M, et al. BMJ Glob Health 2018;3:e000625. doi:10.1136/bmjgh-2017-000625
BMJ Global Health
social morbidity (OR 1.05 (95% CI 1.01 to 1.10)), but 
not for medical or obstetric morbidity. For each of the 
four morbidities, there was however evidence (p<0.001 
in all cases) of heterogeneity between the countries in 
the effects of SES and education on the risk of morbidity 
(table 4).
For India, the likelihood of psychological morbidity 
increased with education, with an estimated OR of 1.53 
Country India Pakistan Kenya Malawi Total
  Speculum examination % % % %
   Abnormal vaginal discharge 11.8 43.5 17.2 52.6 36.4
   Abnormal bleeding 2.2 15.1 33.4 1.3 14.8
   Subtotal 14.0 58.6 50.6 53.9 51.2
  Percentage of study sample 2.4 30.8 5.1 2.8 11.4
*Percentage with abnormal findings calculated as percentage of those who consented to the examination. Percentage of total (n=11 
454) who provided consent for general examination 98.7%, skin and oral cavity examination 92.0%, breast examination 90.0% and 
examination of the abdomen 97.4%.
†Vaginal examination was only offered and consent obtained if clinically indicated; for perineum examination 54.9% of women; for 
speculum examination 20.1% of women.
Table 2 Continued 
Table 3  Infectious and medical or obstetric morbidity identified per country and for all countries combined (number of 
women assessed n=11 454)
Country India Pakistan Kenya Malawi Total
Number of women* 2099 3287 3145 2923 11 454
Infectious morbidity (%)
Condition* Definition
  HIV Positive 0.3 0.3 3.6 14.3 4.8
  Malaria Positive 0.1 0.0 0.2 10.2 2.7
  Syphilis Positive 0.0 0.0 0.3 3.4 0.9
  Positive screening for chest 
infection/possible TB
Symptomatic cough>2 weeks 0.4 0.8 0.7 0.7 0.6
  Number of women with CRP measured† 1873 792 2984 1544 7193
  Septic inflammatory response 
syndrome†
Any two of the following:
-PR>90 beats   per min
-RR>20 breaths per min
-T<36°C or T>38°C
-Raised CRP mg/dL
15.4 25.8 38.2 45.6 32.5
At least one infectious condition 15.9 27.0 40.4 56.5 36.0
Medical or obstetric morbidity (%)
Condition Definition
  Anaemia Hb<110 g/L 61.2 68.7 23.9 41.0 47.9
  Hypertension BP≥140/90, no proteinuria 1.5 4.8 1.8 0.8 2.4
  Pre-eclampsia BP≥140/90, proteinuria (PR≥++) 0.1 1.5 0.4 0.3 0.6
  Urine incontinence Symptom and/or finding on 
examination
1.7 9.6 1.6 1.5 3.6
  Antenatal haemorrhage Symptom and/or finding on 
examination
5.3 8.2 5.2 0.6 4.9
At least one medical or obstetric condition 62.8 71.2 27.1 41.5 50.0
*Where data were missing for a condition, the condition was regarded as being absent. For purposes of deriving morbidities, 
% missing was: HIV 9.7%, malaria 5.3%, syphilis 8.9%, screening for chest infection/TB 2.0%, anaemia 1.9%, BP 2.3%, urine 
incontinence 0.5%.
†CRP was not measured at some primary level facilities in Malawi and Pakistan. Only participants for whom a CRP result was 
obtained are included in these statistics.
BP, blood pressure; CRP, C reactive protein; Hb, haemoglobin; PR, pulse rate; RR, respiratory rate; TB, tuberculosis.
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for each additional level of education, and the esti-
mated odds of each morbidity decreased by a factor 
between 0.58 and 0.85 for each additional level of SES. 
For Pakistan, the estimated odds associated with educa-
tion were similar to those for all countries; however, for 
infectious morbidity the estimated odds increased with 
each additional level of SES by a factor of 1.49 and no 
association with SES was detected for other morbidities. 
For Kenya, the estimated odds associated with education 
for non-physical morbidities were similar to those for 
all countries, with no association with education level 
detected for either of the physical morbidities. However, 
for infectious morbidity the estimated odds increase with 
each additional level of SES by a factor of 1.09 and no 
association with SES was detected for other morbidities. 
For Malawi, the estimated odds associated with education 
for non-physical morbidities were similar to those for all 
countries; a similar association (OR 0.81) with educa-
tion level was also detected for infectious morbidity. For 
infectious morbidity, the estimated odds also decreased 
with each additional level of SES by a factor of 0.90. For 
non-physical morbidities, the odds of morbidity were esti-
mated to increase more substantially with each additional 
level of SES than in analyses for other countries.
dIsCussIon
statement of principal findings
Despite most women reporting good QOL (75.9%) and 
satisfaction with health (78.2%), almost three out of four 
women reported symptoms (73.5%), had abnormal find-
ings on clinical examination (71.3%) or on simple labo-
ratory investigation (73.5%). Overall, one in four women 
(25.1%) had symptoms of psychological morbidity using 
the EPDS as a screening tool. More than one in three 
women (36.6%) reported social morbidity (domestic 
violence and/or substance misuse), with 15.6% of women 
demonstrating both psychological and social morbidity.
Most women (8834; 77.1%) had at least one type of 
identifiable morbidity and a very small number of women 
(138; 1.2%) suffer all four types of morbidity, which 
suggests that morbidity is not limited to a core ‘at-risk’ 
group of women. Women in Pakistan tended to report 
more physical, psychological and social morbidity. Of all 
women tested, 47.4% of women were anaemic with the 
highest prevalence among women from India and Paki-
stan. Using our amended SIRS score, 35.5% of women 
had clinical signs of early infection. When simple clin-
ical algorithms were applied, a source of infection could 
be identified in more than 65% of cases most frequently 
presumed to be gastroenteritis, lower respiratory tract 
infection or a sexually transmitted infection. The prev-
alence of HIV, malaria and syphilis (as confirmed by 
point-of-care testing) was below 5% in all settings except 
Malawi.
Combining all countries and accounting for SES, as 
education level increases the likelihood of medical or 
obstetric, psychological and social morbidity decreases. 
Conversely, after accounting for education level, as SES 
increases, the likelihood of psychological and social 
morbidity increases. However, these effects are not 
consistent across the four countries, with the direction 
of impact (if any) of education or SES changing for some 
morbidities. SES was measured in differing ways between 
the two continents studied. This may account in part 
for some differences, however the estimated ORs for 
SES were statistically significantly in differing directions 
for infectious conditions in both continents. There are 
important differences among the four countries (such 
as higher prevalence of HIV and malaria in Malawi and 
higher prevalence of psychological and social morbidity, 
and morbidity in general, except for infectious morbidity 
in Pakistan). These findings require further research.
strengths of the study
To the best of our knowledge, this is the first study to assess 
maternal morbidity during and after pregnancy using a 
new integrated comprehensive tool to assess self-reported 
subjective physical, psychological and social compo-
nents of ill-health in combination with objective clinical 
and laboratory measurements performed by trained 
healthcare providers. The low refusal rate suggests that 
women attending for care at primary and secondary level 
healthcare facilities in LMIC settings welcome such an 
assessment of their health. Our study also shows that it is 
feasible and acceptable for healthcare providers in these 
settings to screen women for different types of ill-health 
during routine healthcare consultations using validated 
questions and point-of-care diagnostic investigations that 
can be applied in low-resource settings. This study, for 
the first time, provides standardised baseline measure-
ments of maternal morbidity that have been calculated 
using clear and concise methodology, enabling compar-
isons between different settings and countries. Further 
strengths of this study are that both subjective (self-re-
ported symptoms) and objective measures (examination 
and investigations) are included thus helping document 
which areas of ill-health are considered important by 
women themselves, and, does so for up to 12 weeks after 
childbirth.
This study presents estimates of non-severe maternal 
morbidity. It is important to recognise that this does not 
include estimates of incidence of SAMM and/or maternal 
‘near miss’, which are separately defined, and, for which 
global estimates are available. The sum total of both severe 
or acute maternal morbidity and maternal morbidity as 
defined and assessed in this study, clearly constitute a very 
significant burden of disease and risk for women at the 
time of pregnancy and childbirth. Much of this burden 
of disease could be diagnosed, treated and prevented, if, 
the current ANC and PNC care packages are expanded 
with regard to both content and quality.
Weaknesses of the study
This was an observational cross-sectional study using 
purposive sampling that represents convenience samples 
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as opposed to population samples from a representative 
framework and hence is limited in terms of the sections 
of the population it represents. SES is a complex factor 
that needs to be carefully considered. The results for the 
study population in India seem to be contrary to other 
countries with higher education level being associated 
with increased risk of psychological morbidity while 
higher SES associated with reduced risk of morbidity. At 
present, there is no international consensus on how to 
measure SES. This requires further research. Our find-
ings are however in line with those reported in the Global 
Burden of Disease studies. These studies included a new 
composite indicator Socio demographic Index (SDI), 
which includes measures of per capita income, educa-
tion and fertility rate. Country-specific drivers of disease 
burden where found to be higher than expected based 
on SDI.24
This study population includes women who accessed a 
healthcare facility for routine ANC, delivery or PNC and 
excludes those women who did not access care. Thus, the 
prevalence of morbidity can be expected to be higher 
(for women who are ill but not able to access care) or 
lower (for women who feel well and do not see the need 
to access care). However, this was primarily a pragmatic 
study to assess the needs of women who access routine 
care during or after pregnancy and childbirth. At least 
77% of women access ANC once in sub-Saharan Africa 
and Southeast Asia.13 ANC and PNC care packages were 
designed several decades ago and are currently in process 
of being updated. It is important that these care pack-
ages are expanded to meet the identified health needs 
of women.
Absence of a response for any morbidity was taken as 
absence of the sign/symptom/abuse/contribution to 
depression score. For most instances of isolated missing 
values, this approach seems likely to be correct. However, 
lack of recording of presences would result in underesti-
mation of the prevalence of the morbidity. The amount 
of data missing would not result in >5% relative change 
in estimate. For the analyses of associations such errors 
of classification would also reduce the power to detect 
association.
strengths and weaknesses in relation to other studies, 
discussing particularly any differences in results
As this is the first study to assess physical, psychological and 
social components of ill-health comprehensively in four 
LMIC, there is little data in the literature against which to 
compare the overall burden of maternal morbidity. There 
are early reports of population surveys or health camps, 
which tried to identify maternal ill-health in Uganda 
and Egypt.12 25 The community-based survey in Egypt 
reported up to 82.8% of women having morbidity before, 
during or after pregnancy, respectively. One prospective 
study followed up 280 women in rural India for 5 years 
and reported pregnancy-related morbidity in 30% of 
women.5 A larger cross-sectional community-based study 
from India reported that among 3600 women, 41% and 
42.9% had morbidity during and after the last pregnancy, 
respectively.26 In a more recent study, 50.0% of 1732 
women in Malawi and 53.0% of 1727 women in Pakistan 
had a least one medical or obstetric morbidity (infective 
or non-infective) but this relied only on solicited symp-
toms and limited clinical examination.7 Almost none of 
the previous studies included social and psychological 
aspects of ill-health and none included simple one-stop 
laboratory investigations which are now available.
Criteria for reported physical morbidity (symptoms 
and signs) can be subjective and this is the first study to 
objectively demonstrate that it is feasible and acceptable 
to screen women comprehensively for all components 
of health (physical, psychological and social) during a 
‘routine’ health facility visit. There is clearly a need to 
expand the current assessment of health beyond taking a 
simple history of physical symptoms related to the preg-
nancy. Rapid point-of-care tests for the main global infec-
tions such as HIV, syphilis and malaria and for anaemia 
have been developed but are rarely available and/or used 
for women who access ANC and/or PNC. Until now, there 
has been no point-of-care test available to screen for TB 
during and/or after pregnancy. The standard screening 
has consisted of asking whether a woman has a history of 
a persistent productive cough after which sputum testing 
is organised. Unless more regular and accurate screening 
is introduced, it is very likely that, as in this study, this 
results in an underestimation of the prevalence of TB 
during and after pregnancy. This is likely to be especially 
so in Asia where screening for TB is not linked to (opt-
out) HIV screening, which is however in place across 
many sub-Saharan African countries.
The EPDS was used to measure psychological morbidity. 
The EPDS is easy to administer, has proven to be an effec-
tive screening tool and has been previously been validated 
in 12 countries in 14 languages.27 The questionnaire is 
designed to identify possible symptoms of depression and 
anxiety and is not a diagnostic tool per se. The stage of 
pregnancy (antenatal or postnatal) may contribute to the 
variation in the prevalence of psychological morbidity. 
Based on three systematic reviews, these figures are esti-
mated as 4.3%–25% of women during pregnancy; and 
3.2%–48.0% of women following childbirth in LMIC.28–30 
These results are in line with the findings of this study 
that depression was a significant problem along the 
continuum of pregnancy and women were not just ‘at 
risk’ in the postnatal stage.
Meaning of the study: possible mechanisms and implications 
for clinicians or policymakers
Despite women reporting that they have a good QOL 
and are satisfied with their health, there is evidence of 
a significant burden of ill-health (including infectious, 
medical or obstetric, psychological and social morbidity) 
in women during pregnancy and up to 12 weeks after 
childbirth. Even though many women access care during 
pregnancy, at present the available care packages do 
not include comprehensive screening for all forms of 
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ill-health. The focus till now has largely been on detection 
and prevention and treatment of HIV, malaria and syph-
ilis and on emergency preparedness for birth. Although 
laboratory screening for anaemia is advised, this is rarely 
implemented. Screening for psychological or social 
ill-health rarely happens. Finally, treatment pathways for 
women who do have identified health needs are often 
not in place or of very poor quality.
unanswered questions and future research
There is a need to refine and condense the current data 
collection tool, and to build expert consensus regarding 
the inclusion and weight given to each key indicator 
to develop a more concise but still representative and 
composite maternal morbidity assessment tool and score. 
Further research is required to assess the applicability of 
this score as a clinical outcome measure and a strategic 
and programmatic key performance indicator in different 
health systems both in a clinical and research capacity. 
There is also a need for qualitative research to enable 
a better understanding of what women, their families 
and their healthcare providers consider to be maternal 
morbidity, and, to understand the cultural context of 
how women report and describe ill-health including 
psychological morbidity and domestic violence. Anaemia 
and a positive SIRS screen as a marker of infection may 
be useful clinical proxy markers for physical maternal 
morbidity if more sophisticated diagnostic and clinical 
tests are not available or cannot be provided. This will 
require further study.
To be able to provide estimates of change in (any type 
of) maternal morbidity over the course of pregnancy, 
longitudinal cohort studies are needed with assessments 
of morbidity through the course of pregnancy and 
after childbirth. Similarly, additional data would need 
to be collected to assess associations between maternal 
morbidity, pregnancy outcomes and newborn health.
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